Divi's Laboratories Limited vs DRA Consultants Ltd

A side-by-side comparison of Divi's Laboratories Limited (DIVISLAB) and DRA Consultants Ltd (DRA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Divi's Laboratories Limited leads DIVISLAB vs DRA on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability40
  • Growth02
  • Size & financial health40
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

93.92
P/E ratio
16.67
14.90
P/B ratio
1.18
0.32%
Dividend yield
0.00%
₹96.75
EPS
₹1.08

Profitability

DIVISLAB takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

15.32%
Return on equity
8.10%
20.35%
Return on capital
11.07%
32.59%
EBITDA margin
16.39%
24.32%
Net margin
11.30%

Growth

DRA takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.78%
Revenue CAGR (3Y)
61.02%
12.09%
Profit CAGR (3Y)
91.74%

Size & financial health

DIVISLAB takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹2.41L Cr
Market cap
₹20 Cr
₹10,560 Cr
Revenue
₹26 Cr
₹2,568 Cr
Net profit
₹3 Cr
0.00
Debt / equity
0.01
Divi's Laboratories Limited
  • + ["Company has been maintaining a healthy dividend payout of 31.0%", "Company is almost debt free."]
  • − ["Stock is trading at 14.39 times its book value", "The company has delivered a poor sales growth of 8.7% over past five years."]
DRA Consultants Ltd
  • + ["Company has delivered good profit growth of 47.1% CAGR over last 5 years", "Company is almost debt free.", "Company has delivered good sales growth of 31.3% CAGR over last 5 years", "Stock is trading at 0.55 times its book value"]
  • − ["Company has a low return on equity of 9.6% over last 3 years."]
Divi's Laboratories Limited full analysis DRA Consultants Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.